tolnaftate 0.01 MG/MG Topical Powder [Lamisil Defense]
RxNorm concept 692849, branded drug (sbd). Prescribable name: LamISIL AF 1 % Topical Powder.
- RxCUI
- 692849
- Term type
- Branded drug (SBD)
- Status
- Active
curl https://api.healthcare.dev/v1/drugs/rxnorm/692849 \ -H "Authorization: Bearer $HDEV_API_KEY"
Concept
Ingredients and related concepts
Ingredients
Other names
LamISIL AF 1 % Topical Powder; LamISIL Defense 0.01 MG/MG Topical Powder; Lamisil AF 1 % Topical Powder; Lamisil Defense 0.01 MG/MG Topical Powder; tolnaftate 0.01 MG/MG Topical Powder [LamISIL Defense]
Related concepts
- tolnaftate 0.01 MG/MG (SCDC, consists of)
- tolnaftate 0.01 MG/MG [Lamisil Defense] (SBDC, consists of)
- Topical Powder (DF, has dose form)
- Lamisil Defense (BN, has ingredient)
- tolnaftate 0.01 MG/MG Topical Powder (SCD, tradename of)
Linked data
NDCs
- 00067611304
NDC-11s RxNorm links to this concept; linked ones open their FDA product.
Use it
Look up 692849 from code or an agent
curl https://api.healthcare.dev/v1/drugs/rxnorm/692849 \ -H "Authorization: Bearer $HDEV_API_KEY"
Using the healthcare.dev MCP server, look up RxNorm concept 692849. Tell me its name and term type, its ingredients and related concepts, and the NDCs linked to it.
Source: U.S. National Library of Medicine, release 2026-10-05. No license required (Current Prescribable Content). Reference data, not medical advice.